Science & pipeline
At Phairilab, we bridge ancestral botanical knowledge with modern pharmaceutical science to build a new generation of cancer and immune health solutions.
Our research pipeline spans from prescription-grade drug candidates to commercial-ready wellness products, all powered by a fully integrated production model — from plant cultivation to finished formulation.
We build
better products
Clinical Development
We are advancing a portfolio of plant-derived drug candidates targeting cancer and immune modulation.
Our lead candidates are currently undergoing preclinical and early-stage clinical evaluation, conducted in collaboration with certified hospital research centers.
Pipeline of botanical drugs
We are advancing a robust pipeline of botanical drug candidates targeting breast, gastric, pancreatic, and hematological cancers.
Consumer Health Products
Parallel to clinical development, Phairilab maintains a commercial-ready OTC line, including supplements and dermocosmetic formulations, designed to improve patient quality of life.
CS-DiviCare
- Antioxidant activator of innate immune responses
- In process for new food (EFSA)
- Phase I in normal individuals
- (NCT03663881) and Phase II in covid patients (NCT04410510) completed.
CS-SkinBiorepair
- Reduces inflammation generated by gamma-radiation
DiviPet
- Supplement for veterinary cancer control
Integrated Production Model
Unlike conventional biotech, our innovation is powered by vertically integrated sourcing, enabling:
- Controlled and certified cultivation of medicinal plants.
GMP-compliant extraction of Active Pharmaceutical Ingredients (API).
Formulation and manufacturing for capsules, liquids and topical formats.
Scientific Approach & Rationale
Despite advances in oncology, the 5-year survival rate for aggressive cancers (lung, gastric, pancreatic) remains below 35%. Current therapies often fail due to tumor metabolic plasticity.
Phairilab’s polymolecular approach:
- Combines biodiversity with state-of-the-art pharmacology to delivermulti-target therapeutics.
- Targets tumor metabolism toreduce metastasis.
- Enhances immune system activation.
